Pleural mesothelioma is a cancer of the protective lining of the lung, known as the pleura. It is caused by inhaling asbestos fibers into the lungs. It is the most common form of mesothelioma.
What is Pleural Mesothelioma?
Pleural
mesothelioma makes up roughly 75 percent of all mesothelioma diagnoses.
Mesothelioma develops in the lungs when asbestos fibers are inhaled and
lodge into the lining of the lungs (pleura). The average life
expectancy of a person with pleural mesothelioma is between 12 and 21
months depending on how advanced the disease is and the treatments they
receive.
How Is Pleural Mesothelioma Treated?
-
Extrapleural Pneumonectomy (EPP)
This surgery involves the complete removal of the diseased lung and lining. It is a common curative treatment for stage 1 and 2 pleural mesothelioma patients. -
Pleurectomy with Decortication (P/D)
A surgeon spares the lung while removing the diseased pleura and all visible tumors. It is less radical than the EPP, but has led to similar survival times in patients. -
Chemotherapy
The standard chemotherapy drugs for pleural mesothelioma are Alimta and cisplatin. Chemotherapy is often used before and after surgery. -
Radiation
Radiation techniques are being developed to specifically target tumors, leaving healthy lung tissue unharmed. It is the least invasive treatment option for pleural mesothelioma.